Skip to main content
. Author manuscript; available in PMC: 2016 Dec 28.
Published in final edited form as: Cancer. 2015 Oct 6;121(24):4382–4388. doi: 10.1002/cncr.29664

Table 4.

Prevalence of BRCA1/BRCA2 Mutation by Ethnicity and Family Cancer History.

Patient & Family History Number of Patients who underwent BRCA testing BRCA1/BRCA2 Mutation Prevalence Gene/Mutation
Ashkenazi Jewish ancestry 95 13 (13.7%) 1 BRCA1*185delAG
1 BRCA1*5382insC
11 BRCA2*6174delT
 ≥2 FDR or SDR with BRCA-associated cancer* 30 5 (16.7%) 5 BRCA2*6174delT
 1 FDR or SDR with a BRCA-associated cancer* 38 6 (15.8%) 1 BRCA1*185delAG
1 BRCA1*5382insC
4 BRCA2*6174delT
 No family history 27 2 (7.4%) 2 BRCA2*6174delT
Non-Ashkenazi ancestry 56 4 (7.1%) 2 BRCA1
2 BRCA2
 ≥2 FDR or SDR with BRCA-associated cancer* 26 2 (7.7%) 1 BRCA1
1 BRCA2
 1 FDR or SDR with a BRCA-associated cancer* 18 2 (11.1%) 1 BRCA1
1 BRCA2
 No family history 12 0 N/A

FDR = first degree relative; SDR = second degree relative

*

BRCA-associated cancer includes breast, ovarian, pancreas

HHS Vulnerability Disclosure